Thomas Kariuki

Last updated
Thomas Maina Kariuki
Thomas Kariuki.jpg
Born
Kenya
Alma mater University of Nairobi
University of York
Scientific career
Thesis Vaccination strategies against schistosomes in a primate model  (2004)
Doctoral advisor Alan Wilson

Thomas M. Kariuki is a Kenyan biologist who is Chief Executive Officer of the Science for Africa [1] Foundation (SFA Foundation). Kariuki previously served as the Director of Programmes for the Alliance for Accelerating Excellence in Science in Africa [2] (AESA). He was the Director of the Institute of Primate Research/National Museums of Kenya, for seven years. Kariuki’s research interests have spanned the immunology of neglected infectious diseases and he has been involved in global efforts to develop vaccines, drugs and diagnostics for poverty-related diseases. He has published on vaccines and diagnostics development for schistosomiasis (Bilharzia), malaria and co-infections and on policy issues related to biomedical research and funding. He is a Fellow of the African Academy of Sciences (AAS), Senior Fellowship of the European Foundations Initiative for Neglected Tropical Diseases, Presidential honour of the Order of Grand Warrior of Kenya (OGW) for scientific leadership and public service, Honorary Professor of Research of the Liverpool School of Tropical Medicine, LSTM.

Contents

Life

Kariuki grew up in rural Kenya. Many homes in his childhood village did not have electricity or running water, until a decade ago. He notes that many roads in his home village are still not paved, but better governance and infrastructure development of rural roads are shaping many rural lives and putting them on pathways out of poverty. Kariuki obtained his undergraduate degree from the University of Nairobi. Kariuki is an alumnus of the University of Nairobi where he read biosciences, zoology, parasitology and was tutored in immunology by Jasper Mumo. He was awarded a Ph.D. in immunology from the University of York under the mentorship of Alan Wilson, titled Vaccination strategies against schistosomes in a primate model.

He is married with two daughters.

Career

Kariuki served for seven years as director of the Institute of Primate Research and the National Museums of Kenya, a biomedical research and conservation biology centre. His research includes the study of infectious diseases, and enabling the development of vaccines, diagnostics, drugs for diseases that affect areas of poverty such as investigating the influence of parasitic/worm infections on vaccination outcomes. His early research work started on bovine immunology at the International Livestock Research Institute (ILRI) which is a CGIAR Nairobi based centre where he was inducted and mentored into immunology by Prof Cynthia Baldwin, who is currently based at UMass, Amherst. He also conducted joint work at IPR and was as a research associate at Case Western Reserve University in Cleveland, Ohio, with their global health team led and mentored by Chris King, focused on the vaccines and diagnostic development for schistosomiasis (Bilharzia), malaria and co-infections. [3]

In 2017 the Liverpool School of Tropical Medicine awarded Kariuki an honorary professorship in recognition of his past and present collaborations with the school, and his efforts to "accelerate world-class research, foster innovation and promote scientific leadership in Africa". [4] Over the years he has collaborated with teams at LSTM, where he has worked with David Molyneux researching neglected tropical diseases, with Imelda Bates who leads the LSTM Capacity Development Unit for the ongoing DELTAS Africa Learning Research Programme; and on the advisory board with the LSTM team led by Rob Harrison working on NTD Snakebite Venom.

In January 2015, Kariuki was appointed to lead the Alliance for Accelerating Excellence in Science in Africa (AESA), originally established by the African Academy of Sciences and the African Union Development Agency (AUDA-NEPAD). [5] In his role as Director of Programmes at Alliance for Accelerating Excellence in Science in Africa (AESA), Kariuki advocated and created awareness about the importance of science in addressing Africa's health and development challenges, particularly, the rise of infectious and non-communicable diseases in Africa such as cancer, strokes, diabetes and cardiovascular disease.

In January 2022, Kariuki was appointed Chief Executive Officer of the Science for Africa Foundation (SFA Foundation), a non-profit, pan-African and charitable organisation. He is leading a team that designs and funds programmes, builds networks and partnerships to harness science and innovation to tackle major societal challenges in Africa. The SFA Foundation is implementing 10 programmes and 21 initiatives that include the Developing Excellence in Leadership, Training and Science (DELTAS Africa) supported by Wellcome and the United Kingdom Foreign, Commonwealth and Development Office (FCDO formerly DFID) to amplify Africa-led development of world-class research and scientific leaders on the continent, while strengthening African institutions.

The Grand Challenges Africa (GC Africa) [6] is another programme implemented by the SFA Foundation. GC Africa seeks to promote Africa-led scientific innovations to help countries better achieve the Sustainable Development Goals by awarding seed and scale-up grants to the continent’s most impressive solutions. GC Africa supports big, bold impactful innovative ideas that have a potential for impact, scale and sustainability. [7]

Kariuki sits on the advisory board for the World Health Organization (WHO) technical groups, Coalition for Epidemic Preparedness Innovations (CEPI), LSTM Advisory Board for NTD/Envenoming Group and the Gates Open Research, a platform for publication and open peer review of research funded by the Bill & Melinda Gates Foundation. He provides his expertise to shape global programmes and strategies for promoting health and science. He has previously held the position of President of the Federation of African Immunological Societies and served on the Education Committee of the International Union of Immunological Societies. He is also the founder board member of the African Research Network for NTDs (ARNTD).

Kariuki has spoken at the Women Leaders in Global Health (2020), the World Economic Forum Annual Meeting (2017 and 2019), the Grand Challenges Annual Meeting (2015-2020), the World Health Summit (Innovation for Impact Panel Discussion, 2018) and the Next Einstein Forum (Learning to lead: what capacities do scientists and researchers of tomorrow need, 2018). [8]

Awards and honours

Related Research Articles

<span class="mw-page-title-main">Liverpool School of Tropical Medicine</span> Tropical medicine teaching and research institution

The Liverpool School of Tropical Medicine (LSTM) is a higher education institution with degree awarding powers and registered charity located in Liverpool, United Kingdom. Established in 1898, it was the first institution in the world dedicated to research and teaching in tropical medicine. The school has a research portfolio of over £220 million, assisted by funding from organisations such as the Bill & Melinda Gates Foundation, Wellcome Trust and Department for International Development (DFID).

<span class="mw-page-title-main">Tropical medicine</span> Interdisciplinary branch of medicine

Tropical medicine is an interdisciplinary branch of medicine that deals with health issues that occur uniquely, are more widespread, or are more difficult to control in tropical and subtropical regions.

<span class="mw-page-title-main">Stanley Plotkin</span> American physician

Stanley Alan Plotkin is an American physician who works as a consultant to vaccine manufacturers, such as Sanofi Pasteur, as well as biotechnology firms, non-profits and governments. In the 1960s, he played a pivotal role in discovery of a vaccine against rubella virus while working at Wistar Institute in Philadelphia. Plotkin was a member of Wistar’s active research faculty from 1960 to 1991. Today, in addition to his emeritus appointment at Wistar, he is emeritus professor of Pediatrics at the University of Pennsylvania. His book, Vaccines, is the standard reference on the subject. He is an editor with Clinical and Vaccine Immunology, which is published by the American Society for Microbiology in Washington, D.C.

<span class="mw-page-title-main">African Academy of Sciences</span>

The African Academy of Sciences (AAS) is a non-aligned, non-political, not-for-profit, pan-African learned society formed in 1985.

<span class="mw-page-title-main">Neglected tropical diseases</span> Diverse group of tropical infectious diseases which are common in developing countries

Neglected tropical diseases (NTDs) are a diverse group of tropical infections that are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens, such as viruses, bacteria, protozoa, and parasitic worms (helminths). These diseases are contrasted with the "big three" infectious diseases, which generally receive greater treatment and research funding. In sub-Saharan Africa, the effect of neglected tropical diseases as a group is comparable to that of malaria and tuberculosis. NTD co-infection can also make HIV/AIDS and tuberculosis more deadly.

The Kenya Medical Research Institute (KEMRI) is a state corporation established through the Science and Technology (Amendment) Act of 1979,, during the tenure of Nicholas Biwott as Minister of State, as the national body responsible for carrying out health research in Kenya.

<span class="mw-page-title-main">Peter Hotez</span> American scientist, pediatrician, and advocate

Peter Jay Hotez is an American scientist, pediatrician, and advocate in the fields of global health, vaccinology, and neglected tropical disease control. He serves as founding dean of the National School of Tropical Medicine, Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, where he is also Director of the Texas Children's Hospital Center for Vaccine Development and Endowed Chair in Tropical Pediatrics, and University Professor of Biology at Baylor College of Medicine.

<span class="mw-page-title-main">Unlimit Health</span> Non-profit organisation

Unlimit Health is an international organisation working to end parasitic disease. The organisation partners with affected countries, sharing evidence and expertise to eliminate preventable infections, through technical and financial support to ministries of health, in line with their strategies and plans, to strengthen health systems within affected communities.

Thumbi Ndung’u is a Kenyan-born HIV/AIDS researcher. He is the deputy director (Science) and a Max Planck Research Group Leader at the Africa Health Research Institute (AHRI) in Durban, South Africa. He is Professor of Infectious Diseases in the Division of Immunity and Infection, University College London. He is Professor and Victor Daitz Chair in HIV/TB Research and Scientific Director of the HIV Pathogenesis Programme (HPP) at the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal. He holds the South African Research Chair in Systems Biology of HIV/AIDS. He is an Adjunct Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health. He is the Programme Director of the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a research and capacity building initiative funded by the African Academy of Sciences and the Wellcome Trust.

The London Declaration on Neglected Tropical Diseases was a collaborative disease eradication programme launched on 30 January 2012 in London. It was inspired by the World Health Organization roadmap to eradicate or prevent transmission for neglected tropical diseases by the year 2020. Officials from WHO, the World Bank, the Bill & Melinda Gates Foundation, the world's 13 leading pharmaceutical companies, and government representatives from US, UK, United Arab Emirates, Bangladesh, Brazil, Mozambique and Tanzania participated in a joint meeting at the Royal College of Physicians to launch this project. The meeting was spearheaded by Margaret Chan, Director-General of WHO, and Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation.

Mundo Sano, or Fundación Mundo Sano, is a scientific, nongovernmental foundation in Argentina working for the prevention and control of communicable diseases such as dengue fever, Chagas disease, malaria, leishmaniasis and soil-transmitted helminthiasis. Its main objective is to facilitate equal access to health and welfare among people who are vulnerable to these otherwise avoidable diseases, mainly by promoting strategic policies for the improvement of the quality of life of affected communities.

The Global Alliance for Livestock Veterinary Medicines (GALVmed), formerly the Global Alliance for Livestock Vaccines (GALV), is a not-for-profit livestock health product development and access partnership. It operates as a public-private partnership and a UK registered charity headquartered in Edinburgh.

Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.

Gopal Dhinakar Raj is an Indian veterinary scientist, an academic and the project director of the Translational Research Platform for Veterinary Biologicals, a partnership program between the Department of Biotechnology and the Tamil Nadu Veterinary and Animal Sciences University. Known for the development of diagnostic test kits for animal and poultry diseases such as Leptospirosis and Egg drop syndrome, Raj is a member of the DBT Task Force on Animal Biotechnology. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2007.

Francisca Mutapi is a Professor in Global Health Infection and Immunity, co-Director of the Global Health Academy at the University of Edinburgh, and Deputy Director of the National Institute for Health Research (NIHR) Global Health Research Unit Tackling Infections to Benefit Africa. She is the first black woman known to have been awarded a professorship by the University of Edinburgh.

Marta Tufet Bayona is a British and Spanish biologist and public health resource coordinator with a specialty in malaria. She is executive director of the UK Collaborative on Development Research.

Evelyn Nungari Gitau is a Kenyan cellular immunologist at the African Academy of Sciences, and was named a Next Einstein Fellow.

<span class="mw-page-title-main">Kevin Marsh (researcher)</span> British Malariologist and academic

Kevin Marsh is a British Malariologist, academic and a researcher. He is a professor of Tropical Medicine and Director of Africa Oxford Initiative at University of Oxford. He is also a senior advisor at African Academy of Sciences.

Misaki Wayengera is a Ugandan physician, academician, and a medical researcher. He serves as a lecturer for Pathology, Immunology and Molecular Biology at Makerere University College of Health Sciences. He is the chairperson of Uganda's Scientific Advisory Committee on COVID-19 for the Ministry of Health and the National Task Force.

The Kigali Declaration on Neglected Tropical Diseases is a global health project that aims to mobilise political and financial resources for the control and eradication of infectious diseases, the so-called neglected tropical diseases due to different parasitic infections. Launched by the Uniting to Combat Neglected Tropical Diseases on 27 January 2022, it was the culmination and join commitment declared at the Kigali Summit on Malaria and Neglected Tropical Diseases (NTDs) hosted by the Government of Rwanda at its capital city Kigali on 23 June 2022.

References

  1. ↑ "Home | Science for Africa Foundation". scienceforafrica.foundation. Retrieved 2023-09-05.
  2. ↑ "The Alliance for Accelerating Excellence in Science in Africa (AESA) | The AAS". www.aasciences.africa. Retrieved 2020-12-14.
  3. ↑ Nyakundi, Ruth K.; Hau, Jann; Ogongo, Paul; Nyamongo, Onkoba; Jeneby, Maamum; Akinyi, Mercy; Mulei, Isaac; Nyundo, Fred; Farah, Idle; Malhotra, Indu; Ozwara, Hastings; King, Christopher L.; Kariuki, Thomas (2022-02-17). "Acquired Clinical Immunity to Malaria in Nonhuman Primates Coinfected with Schistosoma and Plasmodium Parasites". Infection and Immunity. 90 (2): e0046421. doi:10.1128/IAI.00464-21. ISSN   1098-5522. PMC   8853685 . PMID   34871040.
  4. ↑ "LSTM Honorary Professorship for Dr Thomas Kariuki". LSTM. Retrieved 2023-11-14.
  5. ↑ "NEPAD Home | AUDA-NEPAD". www.nepad.org. Retrieved 2023-09-08.
  6. ↑ "Grand Challenges Africa | Science for Africa Foundation". scienceforafrica.foundation. Retrieved 2023-09-08.
  7. ↑ "Calestous Juma Science Leadership Fellowship | Science for Africa Foundation". scienceforafrica.foundation. Retrieved 2023-09-08.
  8. ↑ "Thomas Kariuki | NEF Global Gathering 2018". 2017-11-24. Retrieved 2023-11-14.
  9. ↑ "Fellow | The AAS". Programmes | The AAS. Retrieved 2024-04-09.
  10. ↑ "Professor Tom Kariuki". CPHIA 2021. Retrieved 2024-04-09.
  11. ↑ "LSTM Honorary Professorship for Dr Thomas Kariuki". LSTM. Retrieved 2024-04-09.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.